dc.contributor.author | Price, D. B. | |
dc.contributor.author | Cotton, S. | |
dc.contributor.author | Fielding, S. | |
dc.contributor.author | McMeekin, N. | |
dc.contributor.author | Barnes, P. | |
dc.contributor.author | Briggs, A. | |
dc.contributor.author | Burns, G. | |
dc.contributor.author | Chaudhuri, R. | |
dc.contributor.author | Chrystyn, H. | |
dc.contributor.author | Davies, L. | |
dc.contributor.author | De Soyza, A. | |
dc.contributor.author | Gompertz, S. | |
dc.contributor.author | Haughney, J. | |
dc.contributor.author | Lee, A. | |
dc.contributor.author | Morice, A. | |
dc.contributor.author | Norrie, J. | |
dc.contributor.author | Sullivan, A. | |
dc.contributor.author | Wilson, A. | |
dc.contributor.author | Devereux, G. | |
dc.date.accessioned | 2018-06-11T10:10:07Z | |
dc.date.available | 2018-06-11T10:10:07Z | |
dc.date.issued | 2018-05 | |
dc.identifier.citation | Price , D B , Cotton , S , Fielding , S , McMeekin , N , Barnes , P , Briggs , A , Burns , G , Chaudhuri , R , Chrystyn , H , Davies , L , De Soyza , A , Gompertz , S , Haughney , J , Lee , A , Morice , A , Norrie , J , Sullivan , A , Wilson , A & Devereux , G 2018 , ' Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD : A Pragmatic Multicentre Randomised Placebo Controlled Trial ' , American Journal of Respiratory and Critical Care Medicine , vol. 197 , A7709 . < https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A7709 > | en |
dc.identifier.issn | 1073-449X | |
dc.identifier.other | PURE: 119610527 | |
dc.identifier.other | PURE UUID: f17b05d9-ad37-4668-87b4-caec4aabaacc | |
dc.identifier.other | RIS: urn:9EE66195E7735A26C9A3E6411F040C3C | |
dc.identifier.uri | http://hdl.handle.net/2164/10580 | |
dc.identifier.uri | https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A7709 | en |
dc.description | This abstract is funded by: National Institute for Health Research Health Technology Assessment Presented at mini symposium: B14. LATE BREAKING CLINICAL TRIALS AND FIRST REPORTS IN ASTHMA AND COPD Monday 21st May 2018 | en |
dc.format.extent | 2 | |
dc.language.iso | eng | |
dc.relation.ispartof | American Journal of Respiratory and Critical Care Medicine | en |
dc.rights | Originally Published in: D.B. Price, S. Cotton, S. Fielding, N. McMeekin, P. Barnes, A. Briggs, G. Burns, R. Chaudhuri, H. Chrystyn, L. Davies, A. De Soyza, S. Gompertz, J. Haughney, A. Lee, A. Morice, J. Norrie, A. Sullivan, A. Wilson, and G. Devereux. Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD: A Pragmatic Multicentre Randomised Placebo Controlled Trial. B14. LATE BREAKING CLINICAL TRIALS AND FIRST REPORTS IN ASTHMA AND COPD. May 1, 2018, A7709-A7709. Copyright © 2017 by the American Thoracic Society The final publication is available at https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A7709. | en |
dc.subject | R Medicine (General) | en |
dc.subject | National Institute for Health Research (NIHR) | en |
dc.subject.lcc | R1 | en |
dc.title | Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD : A Pragmatic Multicentre Randomised Placebo Controlled Trial | en |
dc.type | Journal item | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Public Health, Health Services and Primary Care | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.url | https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A7709 | en |